RPGR gene therapy presents challenges in cloning the coding sequence by Martinez-Fernandez De La Camara, C, Cehajic-Kapetanovic, J, MacLaren, RE

Inclusion of PF68 surfactant improves stability of rAAV titer when passed through a surgical device used in retinal gene therapy by Patrício, M, Cox, C, Blue, C, Barnard, A, Martinez-Fernandez De La Camara, C, Maclaren, R

Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa by Orlans, HO, McClements, ME, Barnard, AR, Martinez-Fernandez de la Camara, C, MacLaren, RE

Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina by Chandler, LC, McClements, ME, Yusuf, IH, Martinez-Fernandez de la Camara, C, MacLaren, RE, Xue, K

cGMP-phosphodiesterase inhibition prevents hypoxia-induced cell death activation in porcine retinal explants by Olivares-González, L, Martinez-Fernandez de la Camara, C, Hervás, D, Marín, MP, Lahoz, A, Millán, JM, Rodrigo, R

Developmental expression of the cell cycle regulator p16INK4a in retinal glial cells: a novel marker for immature ocular astrocytes? by Martinez-Fernandez de la Camara, C, Storm, T, Salman, A, Burgoyne, T, Rasmussen, MQ, Orlans, HO, Russell, AJ, Davies, SG, Barnard, AR, MacLaren, RE

Codon-optimized RPGR improves stability and efficacy of AAV8 gene therapy in two mouse models of X-linked retinitis pigmentosa by Fischer, MD, McClements, ME, Martinez-Fernandez de la Camara, C, Bellingrath, J-S, Dauletbekov, D, Ramsden, SC, Hickey, DG, Barnard, AR, MacLaren, RE

Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR by Cehajic-Kapetanovic, J, Xue, K, Martinez-Fernandez de la Camara, C, Nanda, A, Davies, A, Wood, LJ, Salvetti, AP, Fischer, MD, Aylward, JW, Barnard, AR, Jolly, JK, Luo, E, Lujan, BJ, Ong, T, Girach, A, Black, GCM, Gregori, NZ, Davis, JL, Rosa, PR, Lotery, AJ, Lam, BL, Stanga, PE, MacLaren, RE